Next Article in Journal
Influenza Virus-like Particle (VLP) Vaccines Expressing the SARS-CoV-2 S Glycoprotein, S1, or S2 Domains
Previous Article in Journal
The Promise and Challenges of Cyclic Dinucleotides as Molecular Adjuvants for Vaccine Development
 
 
Article

Article Versions Notes

Vaccines 2021, 9(8), 918; https://doi.org/10.3390/vaccines9080918
Action Date Notes Link
article xml file uploaded 18 August 2021 12:18 CEST Original file -
article xml uploaded. 18 August 2021 12:18 CEST Update https://www.mdpi.com/2076-393X/9/8/918/xml
article pdf uploaded. 18 August 2021 12:18 CEST Version of Record https://www.mdpi.com/2076-393X/9/8/918/pdf
article html file updated 18 August 2021 12:20 CEST Original file -
article supplementary file uploaded. 23 August 2021 08:34 CEST - https://www.mdpi.com/2076-393X/9/8/918#supplementary
article html file updated 23 August 2021 08:36 CEST Update https://www.mdpi.com/2076-393X/9/8/918/html
Back to TopTop